Comparative study of osteonecrosis of the jaw with bisphosphonates and denosumab in two pharmacovigilance database

被引：0
|
作者：
Trenque, Thierry [1 ]
Canneau, Laura [2 ]
Martin, Salome [2 ]
Tralongo, Federica [2 ]
Morel, Aurore [2 ]
Azzouz, Brahim [2 ]
机构：
[1] CHU Reims, Reims, France
[2] Reims Univ Hosp, Dept Pharmacovigilance & Pharmacoepidemiol, Reims, France
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2022年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
518
引用
收藏
页码：231 / 231
页数：1
相关论文
共 50 条
  • [1] Bisphosphonates, osteonecrosis of the jaw, and pharmacovigilance
    Doogue, Matthew
    NEW ZEALAND MEDICAL JOURNAL, 2006, 119 (1246) : 5 - 7
  • [2] Osteonecrosis of the Jaw with Bisphosphonates: French Pharmacovigilance Data
    T. Trenque
    A. C. Buire
    E. Herlem
    M. L. Germain
    Drug Safety, 2008, 31 : 885 - 885
  • [3] Osteonecrosis of the Jaw with Bisphosphonates: French Pharmacovigilance Data
    Trenque, T.
    Molla, A.
    Herlem, E.
    Germain, M. L.
    DRUG SAFETY, 2009, 32 (10) : 987 - 988
  • [4] Osteonecrosis of the Jaw with Bisphosphonates: French Pharmacovigilance Data
    Trenque, T.
    Buire, A. C.
    Heriem, E.
    Germain, M. L.
    DRUG SAFETY, 2008, 31 (10) : 937 - 937
  • [5] Denosumab, an alternative to bisphosphonates but also associated with osteonecrosis of the jaw — what is the risk?
    British Dental Journal, 2015, 219 (3) : 117 - 117
  • [6] Osteonecrosis of the jaw in patients transitioning from bisphosphonates to denosumab treatment for osteoporosis
    P. J. Voss
    D. Steybe
    P. Poxleitner
    R. Schmelzeisen
    C. Munzenmayer
    H. Fuellgraf
    A. Stricker
    W. Semper-Hogg
    Odontology, 2018, 106 : 469 - 480
  • [7] Medication-related osteonecrosis of the jaw associated with bisphosphonates and denosumab in osteoporosis
    Bagan, J.
    Peydro, A.
    Calvo, J.
    Leopoldo, M.
    Jimenez, Y.
    Bagan, L.
    ORAL DISEASES, 2016, 22 (04) : 324 - 329
  • [8] Osteonecrosis of the jaw in patients with dental prostheses being treated with bisphosphonates or denosumab
    Niibe, Kunimichi
    Ouchi, Takehito
    Iwasaki, Ryotaro
    Nakagawa, Taneaki
    Horie, Nobuyuki
    JOURNAL OF PROSTHODONTIC RESEARCH, 2015, 59 (01) : 3 - 5
  • [9] Risk of Osteonecrosis of the Jaw under Denosumab Compared to Bisphosphonates in Patients with Osteoporosis
    Everts-Graber, J.
    Lehmann, D.
    Burkhard, J. P.
    Schaller, B.
    Gahl, B.
    Hauselmann, H. J.
    Studer, U.
    Ziswiler, H. R.
    Reichenbach, S.
    Lehmann, T.
    SWISS MEDICAL WEEKLY, 2022, 152 : 8S - 8S
  • [10] Osteonecrosis of the jaw in patients transitioning from bisphosphonates to denosumab treatment for osteoporosis
    Voss, P. J.
    Steybe, D.
    Poxleitner, P.
    Schmelzeisen, R.
    Munzenmayer, C.
    Fuellgraf, H.
    Stricker, A.
    Semper-Hogg, W.
    ODONTOLOGY, 2018, 106 (04) : 469 - 480
12345